Jonathan Scheiman

Company: Fitbiomics

Job title: Co-Founder & Chief Executive Officer

Seminars:

Advancing Next-Generation Probiotics: Translating FitBiomics’ Clinical & Preclinical Data into Performance and Health Innovations 11:00 am

Harnessing the Gut Microbiome for Human Performance – Exploring FitBiomics’ latest clinical and preclinical data on next-generation probiotics derived from elite athletes and their potential to enhance metabolism, endurance, and recovery Bridging the Gap Between Preclinical Insights and Clinical Validation – Lessons learned from translating microbiome-based discoveries into human trials, including biomarker-driven approaches to assess…Read more

day: Conference Day Two, Track Two, AM

Panel Discussion: From Consumer Success to Clinical Impact: How Direct-to-Consumer Microbiome Products Are Shaping Therapeutic Breakthroughs 5:30 pm

Evaluating clinical trial strategies for direct-to-consumer microbiome products: costs, regulatory pathways, and scientific credibility Analyzing the economic viability of trial-based models in the DTC space: profitability, investor interest, and commercialization speed Navigating marketing and regulatory constraints for microbiome therapeutics in a consumer-driven landscapeRead more

day: Conference Day One, 14:30 - 18:00